Another source of outcomes data?


I hadn't heard of this before, but it doesn't surprise me: Drug companies turn to 'Pharma 2.0' (World News Australia). From the article:

    By using smart gadgets to monitor patients in real time, pharmaceutical companies believe they can improve clinical outcomes and establish the cost-effectiveness of treatments.

    The result, according to a report on Thursday from Ernst & Young, will be a host of new collaborations between pharmaceutical companies and businesses in non-traditional areas such as computing, telecoms and even retail.

It also cites examples already in use, such as Bayer's "connecting its glucometer for diabetic children to Nintendo's video-gaming consoles to promote consistent blood sugar testing." Putting some disquieting implications aside, this could provide a whole new source of outcomes data for everyone involved (including, one would think, CME providers).

Please or Register to post comments.

Blog Archive

Sponsored Introduction Continue on to (or wait seconds) ×